Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $2.27 Million - $2.7 Million
46,620 New
46,620 $2.7 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $458,875 - $1.37 Million
12,500 New
12,500 $485,000
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $1.73 Million - $2.31 Million
-48,966 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $2 Million - $2.21 Million
48,966 New
48,966 $2.17 Million
Q4 2021

Feb 11, 2022

SELL
$38.07 - $44.87 $1.03 Million - $1.21 Million
-27,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $1.11 Million - $1.24 Million
27,000 New
27,000 $1.17 Million
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $345,608 - $425,501
-9,900 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $2.41 Million - $2.98 Million
-73,100 Reduced 88.07%
9,900 $380,000
Q4 2018

Jan 30, 2019

BUY
$31.73 - $39.04 $2.63 Million - $3.24 Million
83,000 New
83,000 $2.93 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $132B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.